论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

急性淋巴细胞白血病患儿ABCC2基因多态性与甲氨蝶呤血清浓度和化疗毒性的相关性研究OA北大核心CSTPCD

Association between ABCC2 genetic polymorphisms and serum concentrations and chemotherapy toxicities of methotrexate in children with acute lymphoblastic leukemia

中文摘要英文摘要

目的 考察急性淋巴细胞白血病(ALL)患儿腺苷三磷酸结合盒亚家族C成员2(ABCC2)rs717620 G>A基因多态性对甲氨蝶呤(MTX)血清浓度和化疗毒性的影响.方法 收集ALL患儿的外周血,提取基因组DNA,用基质辅助激光解吸电离飞行时间质谱技术分析ABCC2 rs717620 G>A基因型,用荧光偏振免疫法测定MTX血清浓度,记录MTX化疗后的ALL复发和毒性发生情况,分析ABCC2 rs717620 G>A基因多态性与剂量校正的MTX浓度(C/D比值)、复发和化疗毒性的相关性.结果 研究共纳入患儿127例,rs717620 GG、GA和AA基因型的分布频率分别为82.68%、16.54%、0.78%;G和A等位基因的分布频率分别为90.94%和9.06%.GG基因型患儿的24 h中位C/D比值(11.94μmol·L-1 per g·m-2)低于 GA 和 AA 基因型患儿(12.64 μmol·L-1 per g·m-2),中位 42 h C/D 比值(0.08 μmol·L-1 per g·m-2)高于 GA 和 AA基因型患儿(0.07 μmol·L-1 perg·m-2),复发率(11.42%)低于GA和AA基因型患儿(18.18%),在统计学上差异均无统计学意义(均P>0.05).GG基因型患儿的血液毒性发生率(40.95%)和电解质紊乱发生率(21.90%)显著高于GA和AA基因型患儿(分别为13.64%和0.00%,P<0.05),其余不良事件的发生率在统计学上差异均无统计学意义(均P>0.05).结论 ABCC2 rs717620 GG基因型可能是ALL患儿发生血液毒性和电解质紊乱的危险因素.

Objective To investigate the effects of adenosine triphosphate-binding cassette,sub-family C,member 2(ABCC2)rs717620 G>A polymorphisms on serum concentrations and chemotherapy toxicities of methotrexate(MTX)in children with acute lymphoblastic leukemia(ALL).Methods Peripheral blood samples were obtained from children with ALL to extract genome DNA.Matrix-assisted laser desorption/ionization time of flight mass spectrometry was used to detect the genotypes of ABCC2 rs717620 G>A polymorphisms.Fluorescence polarization immunoassay was employed to determine the serum concentrations of MTX.The incidences of ALL relapse and toxicities were recorded after chemotherapy with MTX.The associations of ABCC2 rs717620 G>A polymorphisms with dose-adjusted serum concentrations(C/D ratios),relapse,and chemotherapy toxicities of MTX were analyzed.Results A total of 127 children were included in the present study.The frequencies of rs717620 GG,GA and AA genotypes were 82.68%,16.54%and 0.78%,respectively.The frequencies of G and A alleles were 90.94%and 9.06%,respectively.Children with the GG genotype had lower median C/D ratios of MTX in 24 h(11.94 μmol·L-1 per g·m-2),higher C/D ratios of MTX in 42 h(0.08 μmol·L-1 per g·m-2),and lower relapse rates(11.42%)than those in GA and AA genotype carriers(12.64 and 0.07 μmol·L-1 per g·m-2,and 18.18%,respectively).However,none of the above differences were statistically significant.The incidences of hematological(40.95%)and electrolyte disorders(21.90%)in children with the GG genotype were significantly higher than those in GA and AA genotype carriers(13.64%and 0.00%,respectively,P<0.05).There were no statistically significant differences in the incidences of other adverse events between patients with the GG genotype and patients with the GA and AA genotypes(all P>0.05).Conclusion ABCC2 rs717620 GG might be a risk factor for hematological and electrolyte disorders in ALL children treated with MTX.

闫安;赵丹琪;王淑梅

首都医科大学附属北京世纪坛医院药学部,北京 100038||首都医科大学药学院临床药学系,北京 100069首都医科大学附属北京世纪坛医院药学部,北京 100038||临床合理用药生物特征谱学评价北京市重点实验室,北京 100038

药学

甲氨蝶呤;急性淋巴细胞白血病;腺苷三磷酸结合盒亚家族C成员2;基因多态性

methotrexate;acute lymphoblastic leukemia;adenosine triphosphate-binding cassette,sub-family member 2;genetic polymorphism

《中国临床药理学杂志》 2024 (005)

645-648 / 4

国家自然科学基金资助项目(81872926);临床合理用药生物特征谱学评价北京市重点实验室基金资助项目(BZ0439)

10.13699/j.cnki.1001-6821.2024.05.003

评论

下载量:0
点击量:0